1 / 12

Aarkstore Market Research Report - Type 2 Diabetes Therapeut

The report estimates the market size for 2013 and provides a forecast until 2020, and covers disease epidemiology, treatment algorithms, and treatment use patterns. For More Details: http://goo.gl/cSK8ZN

addyparker2350
Download Presentation

Aarkstore Market Research Report - Type 2 Diabetes Therapeut

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Aarkstore Market Research Report - Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth To buy this Report Visit http://www.aarkstore.com

  2. Discounted Market Research Reports available on Aarkstore.com Offer valid till 28th February, 2015 • For more inquiries, contact at +91 9987295242 / 022-27564953 • Email: enquiry@aarkstore.com To buy this Report Visit http://www.aarkstore.com

  3. Summary GBI Research, the leading business intelligence provider, has released its latest research, “Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth”, which provides insights into type 2 diabetes in the Asia-Pacific (APAC) markets of China, India, Japan and Australia. The report estimates the market size for 2013 and provides a forecast until 2020, and covers disease epidemiology, treatment algorithms, and treatment use patterns. It also provides in-depth analysis of the pipeline molecules, clinical trial failure rates, and recent deals. The report has been built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis carried out by GBI Research’s team of industry experts. In 2013, the value of the type 2 diabetes therapeutics market in APAC countries was an estimated $6.5 billion, and it is forecast to grow at a Compound Annual Growth Rate (CAGR) of 7.1% between 2013 and 2020 to $10.5 billion. This strong growth is due to the anticipated approval of products in relatively novel treatment classes, such as Glucagon-Like Peptide-1 (GLP-1) agonists, Dipeptidyl Peptidase-4 (DPP-4) inhibitors, and Sodium Glucose Transporter-2 (SGLT-2) inhibitors, as well as the growth of the prevalence population in the APAC region, particularly in India and China.

  4. Scope The report analyzes the treatment use patterns, market characterization, pipeline analysis and key licensing and co-development deals of the type 2 diabetes in the APAC markets of China, India, Japan, and Australia.It includes - - A brief introduction to type 2 diabetes, including its pathophysiology, etiology, diagnosis and treatment algorithms- In-depth analysis of currently marketed drugs for type 2 diabetes, including analysis of their safety, efficacy, treatment patterns, and strengths and weaknesses, as well as a heat map comparing them in terms of safety and efficacy- A comprehensive review of the pipeline for type 2 diabetes, including individual analysis of a number of late-stage pipeline drugs that are likely to enter the market during the forecast period; the pipeline is analyzed by Phase distribution, molecule type, program type, mechanism of action and molecular target- Additional in-depth analysis of pipeline drug clinical trials by Phase, trial size, trial duration and program failure rate for each molecule type

  5. Scope - Multi-scenario market forecast data to 2020, taking into account how the market might be affected by the introduction of new drugs, the expiry of key patents on current drugs, and the changes in disease epidemiology across the key developed markets- Discussion of the drivers of and barriers to market growth- In-depth analysis of all licensing and co-development deals that have occurred in the type 2 diabetes market since 2006 To know more about this report click here: http://www.aarkstore.com/pharmaceuticals-healthcare/81464/type-2-diabetes-therapeutics-in-asia-pacific-markets

  6. Reasons To Buy The report will enhance your decision-making capability by allowing you to - - Understand the type 2 diabetes pipeline and the factors that indicate that it is becoming more innovative- Examine detailed profiles for promising pipeline products and gain an insight into how and with whom they are likely to compete in the market- Follow the trends in type 2 diabetes clinical trial size and duration in relation to industry averages- Assess the potential risk of future developmental programs for type 2 diabetes therapeutics, depending on the mechanism of action, by taking into account the recorded clinical trial failure rates- Examine the growth patterns expected for the type 2 diabetes market over the forecast period and the countries that are expected to contribute the most to this growth, allowing you to devise a more effectively tailored country strategy through an understanding of key drivers and barriers- Accelerate and strengthen your market position by identifying key companies for strategic partnerships

  7. Table of Contents Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth Marketed Products Pipeline Analysis by Molecule Type Type 2 Diabetes Market Deals and Strategic Consolidations

  8. Price Chart Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth Product Price : Click Here To View OR Purchase Report:

  9. Related Market Research Report • Generic Drugs Market in Japan 2015-2019 • Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 • Metastatic Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 • Lupus Erythematosus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 • Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 • Malaria-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  10. Metastatic Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 • Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 • Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 • Meningitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 • Pharmaceuticals & Healthcare Market Research Reports

  11. About Aarkstore Enterprise • Aarkstore Enterprise provides Industry and Market Analysis and Research Report with expertise and technology knowledge on business improvement and market acquisition. • Aarkstore achieved its debut pad in the year 2008 to explore, work on assignments and cater worldwide clients and business giants with business research on trends, markets and technologies. The latest set of applications guarantees active analysis and Market Research understanding for budding enterpriser and consultants to relate industry ground research.

  12. Contact Us Office Office No. - 809, 8th Floor, B-Wing, Mahaavir Icon,  Plot No.- 89 & 90, Sector-15, CBD-Belapur, Navi Mumbai – 400614,  Maharashtra, India. Telefax No: +91 22 4127 6660 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit : http://www.aarkstore.com OR Mail us at : contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news

More Related